Management of the Axilla in Breast Cancer, Implication for Diagnosis, Prognosis, Treatment, and Morbidity

By Overgaard Jens  

Acta Oncologica, Vol. 39, Iss. 3, 2000-10 ,pp. : 259-260

Informa Healthcare

Access to resources Recommend Favorite

Impact of the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial on Clinical Management of the Axilla in Older Breast Cancer Patients: A SEER-Medicare Analysis

By Caretta-Weyer Holly   Greenberg Caprice   Wilke Lee   Weiss Jennifer   LoConte Noelle   Decker Marquita   Steffens Nicole   Smith Maureen   Neuman Heather  

Annals of Surgical Oncology, Vol. 20, Iss. 13, 2013-12 ,pp. : 4145-4152

Springer Publishing Company

Access to resources Recommend Favorite

Targeted agents in gastrointestinal cancer: a reality in clinical practice

By Van Cutsem Eric  

Targeted Oncology, Vol. 3, Iss. 2, 2008-04 ,pp. : 57-57

Springer Publishing Company

Access to resources Recommend Favorite

Benefits and Harms in Avoiding Axilla Lymphadenectomy in Breast Cancer

By Liakakos Theodore  

Annals of Surgical Oncology, Vol. 15, Iss. 10, 2008-10 ,pp. : 2978-2979

Springer Publishing Company

Access to resources Recommend Favorite

Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics

By Vasen H.F.A.   Haites N.E.   Evans D.G.R.   Steel C.M.   Moller P.   Hodgson S.   Eccles D.   Morrison P.   Stoppa Lyonet D.   Chang-Claude J.   Caligo M.  

European Journal of Cancer, Vol. 34, Iss. 12, 1998-11 ,pp. : 1922-1926

Elsevier

Access to resources Recommend Favorite